Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2025 Jan 13;111(3):117-124.
doi: 10.1136/heartjnl-2024-324677.

Coronary microvascular function and atherosclerotic plaque burden in ischaemia and no obstructive coronary arteries: a secondary analysis of the CorMicA trial

Affiliations
Randomized Controlled Trial

Coronary microvascular function and atherosclerotic plaque burden in ischaemia and no obstructive coronary arteries: a secondary analysis of the CorMicA trial

Daniel T Y Ang et al. Heart. .

Abstract

Background: The relationship between atherosclerosis and endotypes of myocardial ischaemia with no obstructive coronary artery disease (INOCA) is unclear. We investigated potential associations between cumulative atherosclerotic plaque burden quantified using the Gensini score, novel invasive indices of coronary microvascular function (microvascular resistance reserve (MRR); resistive reserve ratio (RRR)) and related INOCA endotypes.

Methods: Coronary angiography and invasive coronary function tests were simultaneously acquired in the CorMicA cohort. A comprehensive physiological assessment was performed using both a thermodilution-based diagnostic guidewire and intracoronary acetylcholine provocation testing. Angiograms were examined for luminal stenosis in each segment of the SYNTAX coronary model. Cumulative plaque burden was quantified using the Gensini score, which incorporated both the number of diseased coronary segments and stenosis severity. Results were compared with indices of microvascular function and INOCA endotypes. Angiographic analyses were performed blind to coronary physiology findings.

Results: In 151 participants (median age 61 years; 73.5% female) without flow-limiting coronary artery disease, medical history included 41.7% smoking, 63.6% hypertension and 19.2% diabetes mellitus. The left anterior descending artery underwent diagnostic guidewire testing in 85.4%, and 55.0% of participants had abnormal coronary flow reserve (CFR) and/or Index of Microcirculatory Resistance (IMR). The median Gensini score was 6.0 (IQR 2.5-11.0). CFR (p=0.012), MRR (p=0.026) and RRR (p=0.026), but not IMR (p=0.445), were univariably associated with raised Gensini scores. These significant effects persisted in multivariable models controlling for potential confounders. Considering INOCA endotypes, Gensini scores differed among participants with microvascular angina (MVA) (7.0 (2.5-11.0)), vasospastic angina (VSA) (4.5 (2.0-10.0)), mixed MVA/VSA (9.0 (5.0-11.5)) and non-cardiac symptoms (3.5 (1.5-8.0)); Kruskal-Wallis p=0.030.

Conclusions: Reduced CFR, MRR and RRR, and MVA were associated with increased coronary atherosclerotic plaque burden, as evidenced by higher Gensini scores. These novel findings provide a mechanistic link between INOCA and cardiovascular events, reinforcing the importance of antiatherosclerosis therapy in patients with MVA.

Keywords: Angina Pectoris; Atherosclerosis; Cardiovascular Diseases; Coronary Angiography; Microvascular Angina.

PubMed Disclaimer

Conflict of interest statement

Competing interests: Dr TF received consulting fees from BioExcel; honoraria from Abbott, Boehringer, Novartis. Dr SW received honoraria from Abbott, AstraZeneca, Biosensors, Boston Scientific, Daiichi Sankyo, GE Healthcare and ShockWave Medical. Dr KR received honoraria from AstraZeneca and Abbott. Dr MM received consulting fees from Abbott, Boston Scientific and ShockWave Medical; honoraria from International Medical Device Solutions and Medtronic. Dr KGO received honoraria from Abbott, Biosensors International and Boston Scientific; full-time employee of Biosensors International since May 2020. Dr CB receives research funding from the British Heart Foundation grant (RE/18/6134217, PG/19/28/34310), Chief Scientist Office, EPSRC (EP/R511705/1, EP/S030875/1) and Medical Research Council (MR/S018905/1). None of the declared interests regards the submitted work. All other authors have nothing to disclose.

Figures

Figure 1
Figure 1. Cumulative atherosclerotic burden as defined by the Gensini score, stratified according to clinical endotype. Diagnoses were made based on combined invasive diagnostic guidewire and pharmacological provocation testing. Impaired coronary flow reserve (CFR <2.0) or elevated index of microcirculatory resistance (IMR ≥25) are indicative of coronary microvascular dysfunction. Coronary microvascular dysfunction is associated with a higher Gensini score. CFR, coronary flow reserve; IMR, Index of Microcirculatory Resistance.

References

    1. Kunadian V, Chieffo A, Camici PG, et al. An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group. Eur Heart J. 2020;41:3504–20. doi: 10.1093/eurheartj/ehaa503. - DOI - PMC - PubMed
    1. Ong P, Camici PG, Beltrame JF, et al. International standardization of diagnostic criteria for microvascular angina. Int J Cardiol. 2018;250:16–20. doi: 10.1016/j.ijcard.2017.08.068. - DOI - PubMed
    1. Beltrame JF, Crea F, Kaski JC, et al. International standardization of diagnostic criteria for vasospastic angina. Eur Heart J. 2017;38:2565–8. doi: 10.1093/eurheartj/ehv351. - DOI - PubMed
    1. Boerhout CKM, Lee JM, de Waard GA, et al. Microvascular resistance reserve: diagnostic and prognostic performance in the ILIAS registry. Eur Heart J. 2023;44:2862–9. doi: 10.1093/eurheartj/ehad378. - DOI - PMC - PubMed
    1. Lee SH, Choi KH, Hong D, et al. Prognostic Implications of Microvascular Resistance Reserve in Symptomatic Patients With Intermediate Coronary Stenosis. JACC: Cardiovascular Interventions. 2024;17:786–97. doi: 10.1016/j.jcin.2024.01.008. - DOI - PubMed

Publication types

MeSH terms